Related Experiment Video
Updated: May 20, 2026

Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Heparin surface modified intraocular lenses in uveitis
1Academic Unit of Ophthalmology, Birmingham and Midland Eye Hospital, Birmingham, UK.
Heparin surface modified intraocular lenses (HSM-IOL) show promising safety and efficacy in cataract surgery for uveitis patients. The study found improved visual acuity in most patients with minimal complications, suggesting HSM-IOLs are suitable for this population.
Area of Science:
- Ophthalmology
- Biomaterials Science
Background:
- Uveitis poses challenges for cataract surgery due to inflammation and potential complications.
- Intraocular lenses (IOLs) with modified surfaces may offer improved outcomes in complex cases.
Purpose of the Study:
- To evaluate the safety and efficacy of heparin surface modified intraocular lenses (HSM-IOLs) in patients with uveitis undergoing cataract surgery.
- To assess post-operative visual acuity and complication rates associated with HSM-IOL implantation in this patient group.
Main Methods:
- Retrospective analysis of 32 eyes from 28 patients with various types of uveitis.
- Extracapsular cataract extraction with posterior chamber HSM-IOL implantation.
- Follow-up ranging from 2 to 51 months (average 16 months).
Main Results:
- Visual acuity improved in 96.8% of eyes (31/32), with 87.5% achieving 6/18 or better.
- Complications included posterior synechiae (25%), inflammatory deposits on IOLs (15.6%), and YAG laser capsulotomy (9.3%).
- Visual acuity was limited in some cases by pre-existing cystoid macular edema.
Conclusions:
- Heparin surface modified intraocular lenses (HSM-IOLs) demonstrate minimal post-operative complications in uveitis patients.
- HSM-IOLs appear to be safe and effective for cataract surgery in individuals with uveitis.
- Further research may explore long-term outcomes and compare HSM-IOLs with other IOL types in uveitic eyes.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Glaucoma: Overview
Venous Thrombosis III: Interprofessional Care

